Sai Reddy, PhD

Associate Professor of Systems and Synthetic Immunology at ETH Zurich

Speaker

Sai Reddy is an Associate Professor at ETH Zurich in the Department of Biosystems Science and Engineering, located in Basel, Switzerland. His research centers on the cutting-edge fields of systems, synthetic, and computational immunology, with a focus on developing technologies that impact immunotherapy and biotechnology. Prof. Reddy's lab has pioneered innovative methods to reprogram immune cells, contributing to advancements in protein therapeutics and cellular immunotherapy.

In addition to his academic work, Sai Reddy is the founder of three spinoff companies based on technologies emerging from his research: deepCDR Biologics, which specializes in antibody drug discovery and engineering (acquired by Alloy Therapeutics in 2021), Engimmune Therapeutics, focusing on T cell-based cancer immunotherapies, and Encelta, which develops allogeneic immune cell therapies.

Recently, Sai Reddy was appointed as the designated Scientific Director of the Botnar Institute of Immune Engineering (BIIE), a newly established non-profit organization dedicated to advanced research in immunology. The BIIE aims to develop translational solutions for disease diagnosis, treatment, and prevention, with a special focus on global child and adolescent health, supported by a generous endowment of over $1 billion USD from Fondation Botnar.